Compare · IMMU vs NNNN
IMMU vs NNNN
Side-by-side comparison of Immunomedics, Inc. (IMMU) and Anbio Biotechnology (NNNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IMMU and NNNN operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- NNNN carries a market cap of $4.10B.
- NNNN has hit the wire 1 time in the past 4 weeks while IMMU has been quiet.
- Company
- Immunomedics, Inc.
- Anbio Biotechnology
- Price
- -
- $32.64+5.29%
- Market cap
- -
- $4.10B
- 1M return
- -
- +5.80%
- 1Y return
- -
- +289.50%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- n/a
- 2025
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 0
Latest IMMU
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- NorthStar Appoints Peter Pfreundschuh to Board of Managers
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
- SEC Form SC 13G/A filed
- Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer
- Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
Latest NNNN
- SEC Form 6-K filed by Anbio Biotechnology
- SEC Form 6-K filed by Anbio Biotechnology
- Amendment: SEC Form 20-F/A filed by Anbio Biotechnology
- SEC Form 3 filed by new insider Song Suki
- SEC Form 3 filed by new insider Hartzler Nancy
- SEC Form 3 filed by new insider Lau Michael
- SEC Form 3 filed by new insider Tian Chris
- SEC Form 3 filed by new insider Xu Cany
- SEC Form 20-F filed by Anbio Biotechnology
- Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum